News & Articles

Results per page

Selected Filters:

Cepheid Clear Filters

Product News

Cepheid announces WHO prequalification of Xpert HIV-1

7 Apr 2024

Product News

Cepheid COVID tests expected to detect Omicron variant

1 Dec 2021

Industry News

Cepheid receives CE mark for Xpert Xpress CoV-2/Flu/RSV plus

13 Oct 2021

Product News

Cepheid receives emergency use authorization for Xpert Xpress CoV-2/Flu/RSV plus

13 Sept 2021

Product News

New rapid molecular test for tuberculosis can detect resistance in less than 90 minutes

23 Aug 2020

Product News

Cepheid announces development of combination test for four viral infections

17 Jun 2020

Industry News

Cepheid receives FDA emergency use authorization for SARS-CoV-2 test

27 Mar 2020

Product News

30 Minute or Less Molecular Flu/RSV Test Now Available

2 Nov 2016

Product News

Cepheid Xpert<sup>®</sup> Rapid Tests – Your Complete Winter Care Bundle

22 Sept 2016

Industry News

Cepheid Xperience Coming to the UK

30 May 2016

Product News

World's Most Portable Molecular Diagnostics System Unveiled at AACC

6 Aug 2015

Product News

Cepheid Receives FDA Clearance for Expanded Claims on Tuberculosis Test

17 Feb 2015

Product News

Cepheid and FIND Announce European Approval of Xpert HIV-1 Viral Load

19 Jan 2015

Product News

Cepheid Receives FDA Clearance for Xpert Norovirus, the First On-Demand Molecular Test for Detection of Norovirus

19 Dec 2014

Industry News

Cepheid to Develop Xpert Ebola for Countries Worst Hit by Epidemic

20 Nov 2014

Product News

Cepheid Announces ‘Ride Against TB’ Campaign with Custom Chopper Unveiling

29 Jul 2013

Product News

Updated Xpert BCR-ABL Monitor Test Released by Cepheid

30 Jul 2012

Product News

GeneXpert Infinity-80 Receives FDA Clearance for Use with Xpert Flu Assay

24 May 2012

News & Articles

Articles Filter

Search

Selected Filters:

Cepheid announces WHO prequalification of Xpert HIV-1

Cepheid COVID tests expected to detect Omicron variant

Cepheid receives CE mark for Xpert Xpress CoV-2/Flu/RSV plus

Cepheid receives emergency use authorization for Xpert Xpress CoV-2/Flu/RSV plus

New rapid molecular test for tuberculosis can detect resistance in less than 90 minutes

Cepheid announces development of combination test for four viral infections

Cepheid receives FDA emergency use authorization for SARS-CoV-2 test

30 Minute or Less Molecular Flu/RSV Test Now Available

Cepheid Xpert<sup>®</sup> Rapid Tests – Your Complete Winter Care Bundle

Cepheid Xperience Coming to the UK

World's Most Portable Molecular Diagnostics System Unveiled at AACC

Cepheid Receives FDA Clearance for Expanded Claims on Tuberculosis Test

Cepheid and FIND Announce European Approval of Xpert HIV-1 Viral Load

Cepheid Receives FDA Clearance for Xpert Norovirus, the First On-Demand Molecular Test for Detection of Norovirus

Cepheid to Develop Xpert Ebola for Countries Worst Hit by Epidemic

Cepheid Announces ‘Ride Against TB’ Campaign with Custom Chopper Unveiling

Updated Xpert BCR-ABL Monitor Test Released by Cepheid

GeneXpert Infinity-80 Receives FDA Clearance for Use with Xpert Flu Assay

News & Articles

Articles FilterArticles Filter

Search

Selected Filters:

Cepheid announces WHO prequalification of Xpert HIV-1

Cepheid COVID tests expected to detect Omicron variant

Cepheid receives CE mark for Xpert Xpress CoV-2/Flu/RSV plus

Cepheid receives emergency use authorization for Xpert Xpress CoV-2/Flu/RSV plus

New rapid molecular test for tuberculosis can detect resistance in less than 90 minutes

Cepheid announces development of combination test for four viral infections

Cepheid receives FDA emergency use authorization for SARS-CoV-2 test

30 Minute or Less Molecular Flu/RSV Test Now Available

Cepheid Xpert<sup>®</sup> Rapid Tests – Your Complete Winter Care Bundle

Cepheid Xperience Coming to the UK

World's Most Portable Molecular Diagnostics System Unveiled at AACC

Cepheid Receives FDA Clearance for Expanded Claims on Tuberculosis Test

Cepheid and FIND Announce European Approval of Xpert HIV-1 Viral Load

Cepheid Receives FDA Clearance for Xpert Norovirus, the First On-Demand Molecular Test for Detection of Norovirus

Cepheid to Develop Xpert Ebola for Countries Worst Hit by Epidemic

Cepheid Announces ‘Ride Against TB’ Campaign with Custom Chopper Unveiling

Updated Xpert BCR-ABL Monitor Test Released by Cepheid

GeneXpert Infinity-80 Receives FDA Clearance for Use with Xpert Flu Assay

Articles Filter